Progesterone Dosing for Women on 0.1 mg Estrogen with Intact Uterus
For a woman with an intact uterus taking 0.1 mg transdermal estradiol (100 μg patch), the recommended progesterone dose is 200 mg of micronized progesterone orally for 12-14 days every 28 days, or 10 mg medroxyprogesterone acetate (MPA) for 12-14 days per month. 1
Dosing Algorithm Based on Estrogen Formulation
For Transdermal Estradiol (Your 0.1 mg = 100 μg patch):
Sequential (Cyclic) Regimen - First Choice:
- Micronized progesterone (MP): 200 mg orally or vaginally for 12-14 days every 28 days 1
- Alternative: MPA 10 mg for 12-14 days per month 1
- Alternative: Dydrogesterone 10 mg for 12-14 days per month 1
Continuous Combined Regimen (if avoiding withdrawal bleeding):
Why Micronized Progesterone is Preferred
Micronized progesterone is the first-line choice among progestogens because recent studies demonstrate it carries a lower risk of cardiovascular disease and venous thromboembolism compared to synthetic progestins while providing adequate endometrial protection 1. The 2021 Blood Reviews guideline explicitly states MP should be the first choice, with MPA, dydrogesterone, or norethisterone as second-line options 1.
FDA-Approved Dosing Confirmation
The FDA label for progesterone capsules confirms 200 mg orally at bedtime for 12 days sequentially per 28-day cycle for women receiving conjugated estrogens 2. This dose was validated in clinical trials showing only 6% incidence of hyperplasia versus 64% with unopposed estrogen 2. While this FDA data specifically references conjugated estrogens at 0.625 mg, the principle of endometrial protection applies to your transdermal estradiol dose.
Critical Dosing Considerations
The dose of progestogen depends on the estrogen dose administered 1. Your 0.1 mg (100 μg) transdermal estradiol patch is considered a standard replacement dose, falling within the typical range of 50-100 μg used in hormone therapy 1. This dose requires full endometrial protection.
Common Pitfall to Avoid
Do not underdose the progestogen. Research shows wide inter-patient variation in endometrial response—even with adequate progestogen doses, some women show proliferative changes 3. The doses recommended above represent the minimum proven effective for endometrial protection. Using lower doses (such as 100 mg micronized progesterone daily in sequential regimens) has not been adequately validated for endometrial safety 4.
Administration Details
Take micronized progesterone at bedtime 2. Some women experience drowsiness, dizziness, or rarely blurred vision after taking progesterone capsules 2. Taking it at bedtime minimizes these effects and may improve compliance.
If swallowing capsules is difficult, take with a full glass of water while standing 2.
Monitoring Requirements
Any unexpected vaginal bleeding requires immediate endometrial evaluation with ultrasound and biopsy 5. Have a low threshold for endometrial sampling, as no clear bleeding pattern reliably predicts abnormal histology 5.
The sequential regimen typically produces predictable monthly withdrawal bleeding. If you prefer to avoid bleeding, switch to a continuous combined regimen, though breakthrough bleeding may occur initially 5.
Alternative Formulations
If oral progestogens cause intolerable side effects (mood changes, bloating, sleep disturbance), consider 5:
- Vaginal micronized progesterone 200 mg for 12-14 days per month (same dose, different route) 1
- Transdermal combined patches containing estradiol plus levonorgestrel 1
The 2011 AACE guidelines note that vaginal progesterone may achieve adequate endometrial protection with fewer systemic side effects, though this is based on limited data in menopausal women 5.